Emerald Health Therapeutics Inc EMHTF

RE:My revenue - share price calculations for 1 year from today.

[Joham13]

Emerald is aiming to significantly expand product sales in conjunction with adult-use legalization in the summer of 2018. The company expects cannabis supply from the first 250,000 square foot phase of its Pure Sunfarms 50/50 partnership prior to legalization. Completion of conversion of Sunfarms' second phase of 250,000 square feet in its 1.1 million square foot greenhouse is targeted for 3Q 2018.

With its wholly owned facility, Emerald is targeting completion of construction of its second phase of 75,000 square feet of cultivation space in 3Q 2018 and its third phase of over 350,000 square feet -- amounting to over 500,000 square feet -- by the end of 2018. Emerald's new facility will house corporate offices and have additional space for extraction and other activities.